Loading insider details...
Beta
Latest Form 4 (Jul 17, 2026): Grant/Award of 25,000 GANX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 17, 2026 | Gain Therapeutics, Inc. (GANX) | Grant/Award | 25,000 | n/a |
| Jun 5, 2026 | Minerva Neurosciences, Inc. (NERV) | Grant/Award | 50,000 | n/a |
| Dec 23, 2025 | Minerva Neurosciences, Inc. (NERV) | Grant/Award | 50,000 | n/a |
| Jun 25, 2025 | Gain Therapeutics, Inc. (GANX) | Grant/Award | 15,000 | n/a |
| Dec 6, 2024 | Minerva Neurosciences, Inc. (NERV) | Grant/Award | 12,500 | n/a |
| Jun 27, 2024 | Gain Therapeutics, Inc. (GANX) | Grant/Award | 15,000 | n/a |
| Sep 29, 2023 | Minerva Neurosciences, Inc. (NERV) | Grant/Award | 12,500 | n/a |
| Jun 26, 2023 | Gain Therapeutics, Inc. (GANX) | Grant/Award | 10,500 | n/a |
| Sep 22, 2022 | Gain Therapeutics, Inc. (GANX) | Grant/Award | 10,500 | n/a |
| Jun 28, 2022 | Minerva Neurosciences, Inc. (NERV) | Grant/Award | 2,500 | n/a |